3963 Maple Avenue
Suite 350
Dallas, TX 75219
United States
972 499 3350
https://instilbio.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 49
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Bronson Crouch | Chairman & CEO | 1,14M | N/D | 1973 |
Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 741,52k | N/D | 1969 |
Dr. Mark E. Dudley Ph.D. | Chief Scientific Officer | N/D | N/D | N/D |
Dr. Robert Hawkins MBBS, Ph.D. | Head of Research & Development | 218,72k | N/D | N/D |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
L'ISS Governance QualityScore di Instil Bio, Inc. al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 8; diritti degli azionisti: 8; retribuzione: 9.